Anika Therapeutics (ANIK) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of$0.02 per share. This compares to a loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +100.00$0.13 per share when it actually produced a loss of $0.13, delivering no surprise.Over the last four quarters, the ...